Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer

The impact of various neoadjuvant treatment regimens on the level of enzyme immunoassay-determined angiogenic markers of endothelial growth factor and its type 2 receptor in tumor cytosol and serum was assessed in 30 patients with locally advanced breast cancer (BC). The findings suggest the promise...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/210
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The impact of various neoadjuvant treatment regimens on the level of enzyme immunoassay-determined angiogenic markers of endothelial growth factor and its type 2 receptor in tumor cytosol and serum was assessed in 30 patients with locally advanced breast cancer (BC). The findings suggest the promises for studies of neoangiogenesis factors mainly in tumor tissue for their possible use as prognostic biological markers in patients with BC.
ISSN:1994-4098
1999-8627